Moreover, HER2 overexpression was also detected in CRC in different studies, varying from 0.5% to 40% (Essapen et al., 2004; Kruszewski et al., 2010; Ingold Heppner et al., 2014). The gene discussed is ERBB2; the disease is colorectal carcinoma.